CD8A and neoplasm: Preclinical experiments have shown that a single dose of HPV mRNA vaccine can induce a strong CD8+ T cell response, exerting a powerful anti-tumor effect, which is superior to HPV protein vaccines and HPV DNA vaccines [95].